Epitomee Medical Stock Beta
| EPIT Stock | 938.20 30.20 3.33% |
Epitomee Medical fundamentals help investors to digest information that contributes to Epitomee Medical's financial success or failures. It also enables traders to predict the movement of Epitomee Stock. The fundamental analysis module provides a way to measure Epitomee Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Epitomee Medical stock.
Epitomee |
Epitomee Medical Company Beta Analysis
Epitomee Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Epitomee Medical has a Beta of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The beta for all Israel stocks is 100.0% lower than that of the firm.
Epitomee Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Epitomee Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Epitomee Medical could also be used in its relative valuation, which is a method of valuing Epitomee Medical by comparing valuation metrics of similar companies.Epitomee Medical is currently under evaluation in beta category among its peers.
Epitomee Fundamentals
| Current Valuation | 339.18 M | |||
| Shares Outstanding | 29.58 M | |||
| Shares Owned By Insiders | 56.83 % | |||
| Shares Owned By Institutions | 20.28 % | |||
| Price To Book | 3.48 X | |||
| Market Capitalization | 318.32 M |
About Epitomee Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Epitomee Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epitomee Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epitomee Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Epitomee Stock
Epitomee Medical financial ratios help investors to determine whether Epitomee Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Epitomee with respect to the benefits of owning Epitomee Medical security.